DW Healthcare Partners, a private equity firm focused primarily on making control investments in North American middle market healthcare companies, has closed its fifth fund.
The fund was oversubscribed and met its cap of USD610 million in total capital commitments. This brings DW Healthcare Partners’ total capital under management to USD1.43 billion.
“We are grateful for the support we have received from both previous and new investors in Fund V. We believe we have earned their trust through our long track record, sourcing model, and differentiated investment strategy,” says DW Healthcare Partners’ Co-Founder and Managing Partner, Andrew Carragher.
DW Healthcare Partners has invested in 34 platform companies and 52 add-ons since 2003. Many of these investments have been sourced through its internal sourcing process, which involves a team of six professionals continuously working to refine and build out its proprietary database of over 43,000 healthcare companies. DW Healthcare Partners has a team of more than 27 professionals across two offices located in Toronto, Ontario and Park City, Utah.
DW Healthcare Partners V (Fund V) will deploy the same investment strategy, as prior funds, of partnering with founders of exceptional middle market healthcare companies while providing its deep industry knowledge and operational expertise to build and accelerate growth. Fund V currently has one platform investment, Cefaly.
M2O Private Fund Advisors acted as DW Healthcare Partners’ placement agent, and Kirkland & Ellis LLP acted as legal counsel.
